IDIBELL has been one of the institutions with more funded projects, up to 10, of which it leads 7, and participates in 3 more projects as a collaborator.
La Marató will finance with 1.5 million euros 10 IDIBELL projects in rare diseases Read More »
Next Saturday, November 28th, researchers of Bellvitge will present their most recent investigations to the general public. The new website Sinergia will broadcast a wide program of virtual talks. Sinergia has been specifically released to celebrate the first virtual edition of the Festival for the Research and Innovation in Health of L’Hospitalet.
New biomedical breakthroughs of Bellvitge, live streaming on November 28th Read More »
A total of 44 researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and Bellvitge University Hospital (HUB) sign an article in the International Journal of Infectious Diseases, where they demonstrate the beneficial effect of the use of corticosteroids added to tocilizumab treatment to improve the prognosis of critical patients of Covid-19.
A new study analyzes the influence of proton pump inhibitor drugs on the risk of false positives in an immunological fecal occult blood test, a test used to detect colorectal cancer.
The Intensive Medicine Service of the Bellvitge University Hospital (HUB) participates, through the Bellvitge Biomedical Research Institute (IDIBELL), in the European ENVISION project, which will develop an intelligent decision support system to improve the monitoring and treatment of patients with Covid-19 in ICUs.
Today, the Teams platform hosted the IDIBELL Kickoff Meeting La Marató 2019, aimed at all those researchers who have obtained a research project within the “Convocatòria 2019 per a l’adjudicació d’ajudes econòmiques a projectes de recerca de càncer” by La La Marató de TV3 Foundation.
This milestone could be achieved thanks to the increased efficacy and mass administration of the vaccine as well as the modernization of screening techniques.
New global strategy to eliminate cervical cancer Read More »
Among the activities proposed by Sinergia are a virtual escape room through the IDIBELL laboratories, family workshops and 360º visits to Bellvitge facilities.
Dr. Fernando Fernández-Aranda is currently the editor-in-chief of the European Eating Disorders Review, a journal that has published a special issue in October focusing on the impact of the pandemic and lockdown on patients with eating disorders and obesity. We spoke with Dr. Fernández-Aranda about this special and the reflections they have extracted.
The impact of the pandemic on people with eating disorders and obesity Read More »
The last month this project, developed by the Catalan Institute of Oncology and IDIBELL, with the collaboration in Portugal of the Pedro Nuñez Institute, has received the awards ” Invertir me Saúde 2020″ and “HINTT Award”.
The European project “Oncommun-ICOnnecta’t” receives two International awards Read More »
